Zevra Therapeutics, Inc. (ZVRA)
NASDAQ · Healthcare
Zevra Therapeutics, Inc. Long Term Debt 2013–2025
Zevra Therapeutics, Inc. annual long term debt history from 2018 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Zevra Therapeutics, Inc. long term debt as of December 31, 2025: 61.9M, a 4.07% increase year-over-year.
- Zevra Therapeutics, Inc. long term debt for 2025 were 61.9M, a 4.07% increase from 2024.
- Zevra Therapeutics, Inc. long term debt for 2024 were 59.5M, a 1074.58% increase from 2023.
- Zevra Therapeutics, Inc. long term debt for 2023 were 5.1M, a 92.51% decrease from 2020.
- Zevra Therapeutics, Inc. long term debt for 2020 were 67.7M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Zevra Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $62 |
| 2024 | $60 |
| 2023 | $5 |
| 2020 | $68 |
| 2019 | $77 |
| 2018 | $81 |
Zevra Therapeutics, Inc. Long Term Debt — FAQ
Zevra Therapeutics, Inc. (ZVRA) long term debt over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ZVRA's long term debt history?
The chart and table above show Zevra Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.